Close Menu
Home › Notable Labs Raises $10M in Series A Financing

Notable Labs Raises $10M in Series A Financing

Sep 06, 2017
|
staff reporter

NEW YORK (360Dx) – San Francisco-based Notable Labs today announced that it has raised $10 million in Series A funding, which it will put toward building its technology platform and team, as well as clinical feasibility studies related to blood cancers.

The firm provides a drug-testing service for oncologists identifying treatment options for blood-cancer patients.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
03
Featured Webinar

Streamlined and High-Precision Cancer Analysis Using an Automated NGS Workflow in the Reference Lab Setting

This webinar will provide an overview of how an international reference laboratory has implemented an automated next-generation sequencing workflow with custom panels for analyzing cancer samples.

Oct
24
Featured Webinar

Designing, Decoding & Delivering on Genetic Testing for Inherited Disease at Versiti

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.

What's Popular?

In Precision Oncology Specialties

  1. USPSTF Formalizes Slightly Expanded BRCA Screening Recommendations

  2. Foundation Medicine to Seek FDA Approval for FoundationOne as CDx to Genentech's Rozlytrek

  3. Xylonix, BioGemex Ink MOU to Develop Point-of-Care Cancer Immunotherapy-Response Diagnostic

  4. Cancer Genetics Posts 15 Percent Rise in Q2 Revenues

  5. Enlighta Partners With LHHC Medical to Develop Early Cancer Detection System

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.